One of the most prestigious magazines „Science“ published an article „A cyclic oligonucleotide signaling pathway in Type III CRISPR-Cas systems“ by Lithuanian scientists Miglė Kazlauskienė, Georgij Kostiuk, Česlovas Venclovas, Gintautas Tamulaitis ir Virginijus Šikšnys from Vilnius University Life Science Center Institute of Biotechnology.
This is the first time for Lithuanian scientists to be recognized by the magazine which is hosting the most advanced and significant scientific ideas in the world. „Science“ publishes on average only 7% of all submissions. The very fact of publication proves once again that Lithuanian scientists are on the verge of the most advanced scientific discoveries of global importance and impact.
Prof. V. Šikšnys and the team have been working on CRISPR-Cas systems for a number of years. Type III CRISPR-Cas systems in prokaryotes provide immunity against invading nucleic acids through the coordinated degradation of transcriptionally-active DNA and its transcripts by the Csm effector complex.
Scientific discovery has been recognized by international business community for its potential in transferring into technologies for further commercialization: Vilnius University and US company „DuPont Pioneer“ in May, 2017 announced about the patent registration in US.
We will meet these scientists at the bi-annual forum „Life Sciences Baltic 2018“ in Vilnius, an established and recognized location in world life science and business for trend-setters.
Save the date – September 26-27, 2018!
Prof. V. Šikšnys
E. Kurauskas photo.